Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.02 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
18-Sep-2019Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trialAdamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix
1-Oct-2022COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patientsDíez Villanueva, Anna; Sanz Pamplona, Rebeca; Solé, Xevi; Cordero, David; Crous Bou, Marta; Guinó, Elisabet; López Dóriga Guerra, Adriana; Berenguer, Antoni; Aussó, Susanna; Paré, Laia; Obón Santacana, Mireia; Moratalla Navarro, Ferran; Salazar Soler, Ramón; Sanjuan, Xavier; Santos, Cristina; Biondo, Sebastián; Diez Obrero, Virginia; Garcia Serrano, Ainhoa; Alonso Aguado, Maria Henar; Carreras Torres, Robert; Closa, Adria; Moreno Aguado, Víctor
9-Jan-2019Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trialGavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix
7-Apr-2021Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancerSchettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia
1-Oct-2019The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX modelsGómez Miragaya, Jorge; Moran, Sebastian; Calleja Cervantes, Maria E.; Collado-Solé, Alejandro; Paré, Laia; Gómez, Antonio; Serra Elizalde, Violeta; Dobrolecki, Lacey E.; Lewis, Michael T.; Diaz-Lagares, Angel; Eroles, Pilar; Prat Aparicio, Aleix; Esteller, Manel; González Suárez, Eva
May-2017Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating populationGómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra Elizalde, Violeta; Prat Aparicio, Aleix; González Suárez, Eva
4-Jan-2021Clinical, pathological and PAM50 gene expression features of HER2-low breast cancerPrat Aparicio, Aleix; Schettini, Francesco; Chic Ruché, Núria; Brasó Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez Sáez, Olga; Adamo, Barbara; Vidal Losada, Maria Jesús; Fernández Martínez, Aranzazu; González Farré, Blanca; Sanfeliu, Esther; Cejalvo Andújar, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H.; Lluch, Ana; Martín, Miguel; Placido, Sabino De; Barnadas, Esther; Locci, Mariavittoria; Peg, Vicente; Fasan, Roberta
19-Mar-2021Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancerGriguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo
14-Jul-2020ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancerGriguolo, Gaia; Brasó Maristany, Fara; González Farré, Blanca; Pascual, Tomás; Chic Ruché, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix